ReviewCurrent urology reports2016
Irreversible Electroporation (IRE) in Renal Tumors.
Review in Current urology reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.
- Pooled it
- Pulsed field ablation in medicine: irreversible electroporation and electropermeabilization theory and applications.Radiology and oncology · 2025Review
- Preclinical Study of Biphasic Asymmetric Pulsed Field Ablation.Frontiers in cardiovascular medicine · 2022Article
- Irreversible electroporation augments checkpoint immunotherapy in prostate cancer and promotes tumor antigen-specific tissue-resident memory CD8+ T cells.Nature communications · 2021Article
- Study on Optimal Parameter and Target for Pulsed-Field Ablation of Atrial Fibrillation.Frontiers in cardiovascular medicine · 2021Article
- Treatment options for localised renal cell carcinoma of the transplanted kidney.World journal of transplantation · 2020Review
- Active surveillance and focal ablation for small renal masses: a better solution for comorbid patients.Archives of medical science : AMS · 2020Article
- An evaluation of irreversible electroporation thresholds in human prostate cancer and potential correlations to physiological measurements.APL bioengineering · 2017Article
- Percutaneous radiofrequency and microwave ablation in the treatment of renal tumors - 10 years of experience.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2017Article
- Focal ablation therapy for renal cancer in the era of active surveillance and minimally invasive partial nephrectomy.Nature reviews. Urology · 2017Review
- [Focal therapy for small renal masses : Observation, ablation or surgery].Der Urologe. Ausg. A · 2016Review
- Irreversible Electroporation: A Novel Ultrasound-guided Modality for Non-thermal Tumor Ablation.Journal of medical ultrasoundReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small renal masses (SRMs) have been traditionally managed with surgical resection. Minimally invasive nephron-sparing treatment methods are preferred to avoid harmful consequences of renal insufficiency, with partial nephrectomy (PN) considered the gold standard. With increase in the incidence of the SRMs and evolution of ablative technologies, percutaneous ablation is now considered a viable treatment alternative to surgical resection with comparable oncologic outcomes and better nephron-sparing property. Traditional thermal ablative techniques suffer from unique set of challenges in treating tumors near vessels or critical structures. Irreversible electroporation (IRE), with its non-thermal nature and connective tissue-sparing properties, has shown utility where traditional ablative techniques face challenges. This review presents the role of IRE in renal tumors based on the most relevant published literature on the IRE technology, animal studies, and human experience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.